Study Group: Ophthalmologists (EU)(?)
Council Members in this Study Group: 320
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Leading Experts in this Study Group
Rudy Nuijts, MD, PhD
Director of Cornea Clinic
Universiteit Maastricht
Director of Cornea Clinic
Universiteit Maastricht
Rudy Nuijts, MD, PhD, is the Director of the Cornea Clinic at Academic Center for Refractive Surgery in Maastricht, Netherlands. Dr. Nuijts has expertise in anterior segment surgery including corneal lamellar transplant surgery, cataract surgery and refractive surgery. He has used the IntraLase femtosecond...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Visudyne teraphy may play a new role in AMD treatment | 04-07-2008
Analysis of:
Positive Results From Visudyne (R) Combination Therapy Study Reported at Annual Macula Society Conference | www.pipelinereview.com
Author: GLG Expert Contributor
1. AMD 2. Anti VEG 3. Visudyne
New molecule for the treatment of rheumatoid arthritis with minor toxicity. | 03-05-2008
Analysis of:
Glenmark’s molecule for Rheumatoid Arthritis - GRC 4039 | www.pipelinereview.com
Author: GLG Expert Contributor
1. Rheumatoid arthritis as an invalidating disease (1% population). 2. Anti TNF-α agents. 3. Clinical trial for inflammatory disorders by Glenmark.
Decreasing the risk of complications in the treatment of wet AMD. | 03-05-2008
Analysis of:
MacuSight Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration | pharmalive.com
Author: GLG Expert Contributor
1. Wet AMD. 2. Macular edema. 3. Intravitreal injection.
Choosing the best treatment for wet AMD. | 03-05-2008
Analysis of:
Comparison of AMD Treatments Trials (CATT): Lucentis — Avastin Trial | www.pipelinereview.com
Author: GLG Expert Contributor
1. Lucentis. 2. Avastin. 3. Cost.
Keeping the privacy of health data. | 03-05-2008
Analysis of:
Google to store patients' health records | news.yahoo.com
Author: GLG Expert Contributor
1. Internet. 2. Medical records. 3. Privacy.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Department Chair
- Physician - Division Head
- Owner
- Professor
- Director
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate